42
S. Kaennakam et al. / Phytochemistry 152 (2018) 36e44
of H and 13C NMR data (Tables 2 and 4) of 10 showed similarity to
those of 6 except that the glucopyranosyl unit (GlcI) of 6 was
replaced by a glucuronopyranosyl unit, the signal of carboxyl group
1
3.3. Extraction and isolation
The dried powder of G. erythroclada roots (10.0 kg) and stem
bark (10.0 kg) were macerated for 3 days with MeOH (each
2 ꢂ 25 L). After evaporation of the solvent in vacuo, 450 g of root
residue and 420 g of stem bark residue were obtained. Each of the
two MeOH residue samples were suspended in H
separated with dianion HP-20, and eluted with H
respectively.
The MeOH-soluble residue (98 g) from the roots was chroma-
tographed over silica gel and eluted with MeOH in EtOAc (0e100%,
stepwise), yielding four fractions (A-D). Fraction A (5 g) was puri-
C
shown at d 172.8 (C-6-GlcA) and the lack of a hydroxymethyl group
in 10. The H and C NMR spectra showed four anomeric protons at
1
13
d
H
4.32 (1H, d, J ¼ 5.5 Hz, H-1-GlcA), 4.43 (1H, d, J ¼ 5.5 Hz, H-1-
GlcII), 5.33 (1H, br s, H-1-Rha), and 5.18 (1H, d, J ¼ 8.1 Hz, H-1-
2
O and then
O and MeOH,
Glc), which were correlated in the HSQC spectrum with anomeric
2
carbons at
drolysis confirmed the presence of a sugar mixture containing
glucose, -glucoronic acid, and -rhamnose. The NMR spectroscopic
data (Table 4) of 10 confirmed the presence of -glucoronic acid
moiety. In addition, the sugar sequence was elucidated by the 2D
NMR data. Thus, 10 was identified as 3-O-[ -rhamnopyranosyl-
1/2)- -glucopyranosyl-(1/3)- -glucuronopyranosyl]-28-
O-( -glucopyranosyl)-3 -hydroxyurs-12-en-28-oic acid.
All isolated compounds (1e11) were evaluated in vitro for their
C
d 103.7, 102.0, 100.4, and 94.3, respectively. Acid hy-
D
-
D
L
b
fied with sephadex LH-20, using CH
give 1 (120 mg). Fraction B (12 g) was repeatedly subjected to silica
gel, eluting with MeOH in CH Cl (1:4), to provide two subfractions,
and then each subfraction was further purified with sephadex LH-
20, using CH Cl -MeOH (1:1) as eluent to afford 2 (95 mg) and 8
(25 mg). Compounds 5 (35 mg) and 11 (45 mg) were achieved from
fraction C (10 g) by siliga gel, eluting with CH Cl -MeOH (4:1).
Fraction D (15 g) was separated by silica gel and eluted with CH Cl
2 2
Cl -MeOH (1:1) as eluent to
a-L
(
b-
D
b-
D
2
2
b
-D
b
2
2
cytotoxicity against KB and HeLa S-3 cell lines and their anti-
inflammatory activity based on the inhibition of NO production in
RAW264.7 cells. Almost all compounds showed inactive cytotox-
icity against two cancer cells, except that compound 4 showed
moderate cytotoxicity against KB and HeLa S-3 cells with IC50
2
2
2
2
-
MeOH (4:1) to obtain two subfractions (Da and Db). Subfraction Da
(5 g) was further purified with sephadex LH-20, eluting with
values of 25.8 and 29.5
oleanane-type saponins have the 28-carboxylic acid based on the
damage of cell membrane like a hemolytic action (Podolak et al.,
m
M, respectively. The cytotoxic effects of
CH
(15 mg) was purified from subfraction Db (2 g) with sephadex LH-
20, eluting with CH Cl -MeOH (1:1).
2 2
Cl -MeOH (1:1), to yield 3 (15 mg) and 4 (11 mg). Compound 9
2
2
2
010). In this research suggested that disaccharide at C-3 of ole-
The MeOH-soluble residue (85 g) from the stem bark was sub-
jected to silica gel and eluted with MeOH in EtOAc (0e100%, step-
wise), to provide three fractions (E-G). Compound 8 (10 mg) was
purified from fraction E (3 g) with sephadex LH-20, eluting with
anane triterpenes, glucuronic acid-rhamnose (4) have more cyto-
toxic effect than glucose-rhamnose (1) and trisaccharide (5).
Compounds 4, 6, 7, 9 and 10 showed moderate anti-inflammatory
with IC50 values of 76.8, 81.4, 69.4, 63.0 and 79.5
All isolated compounds have no affected to RAW264.7 cells at
concentration lower than 300 M. Doxorubicin (IC50 0.16 and
.03 M for KB and HeLa S-3) was used for positive control of
cytotoxicity and dexamethasone (IC50 8.25 mM) was used for posi-
tive control of anti-inflammatory.
m
M respectively.
CH
silica gel and eluted with a gradient of CH
give 6 (10 mg) and 9 (8 mg). Fraction G (17 g) was fractionated by
siliga gel and eluted with CH Cl -MeOH (2:1), to give two sub-
fraction (Ga and Gb). Compound 7 (12 mg) was purified from
subfraction Ga (5 g) with sephadex LH-20, eluting with CH Cl
MeOH (1:1). Subfraction Gb was treated with sephadex LH-20,
using CH Cl -MeOH (1:1) as eluent to yield 10 (9 mg).
2
Cl
2
-MeOH (1:1). Fraction F (20 g) was chromatographed over
2
2
Cl -MeOH (1:4 to 4:1), to
m
0
m
2
2
2
2
-
2
2
3
. Experimental section
3
.3.1. Erythrosaponin A (1)
2
0
3.1. General experimental procedures
Colorless crystals; ½aꢀ -39.7 (c 0.26, MeOH); IR (KBr)
nmax 3428,
D
ꢁ1
1
13
1727, 1645 cm ; H and C NMR data, see Tables 1 and 3; positive
þ
The UVevisible absorption spectra were recorded on a UV-2550
HRESIMS m/z 803.4567 [Mþ Na] (calcd. for
42 68
C H O13Na,
UVevis spectrometer (Shimadzu, Kyoto, Japan). The IR spectra were
measured on a Nicolet 6700 FT-IR spectrometer using KBr discs.
Optical rotations were detected by a Jasco P-1010 polarimeter. NMR
spectra were recorded on a Bruker 400 AVANCE spectrometer
803.4558).
3.3.2. Erythrosaponin B (2)
2
0
Amorphous powder; ½aꢀ -33.3 (c 0.20, MeOH); IR (KBr)
n
max
D
1
13
ꢁ1
1
13
(
400 MHz for H and 100 MHz for C). The HRESIMS were obtained
3425, 1729, 1647 cm
;
H and C NMR data, see Tables 1 and 3;
þ
using a Bruker MICROTOF model mass spectrometer. Single-crystal
positive HRESIMS m/z 819.4500 [Mþ Na] (calcd. for C42
68
H O14Na,
X-ray diffraction analysis was performed on a Bruker ꢂ8 APEXII
819.4507).
Kappa CCD area-detector diffractometer with MoK
a radiation
(
l
¼ 0.71073 Å). Column chromatography was performed with
3.3.3. Erythrosaponin C (3)
2
0
Dianion HP-20, silica gel 60 (0.063e0.200 mm), and Sephadex LH-
2
Amorphous powder; ½aꢀ -74.7 (c 0.54, MeOH); IR (KBr)
n
max
D
ꢁ
1
1
13
0 (25e100
mm, GE Healthcare).
3421, 1725, 1646 cm
;
H and C NMR data, see Tables 1 and 3;
þ
positive HRESIMS m/z 981.5044 [Mþ Na] (calcd. for C42
68
H O13Na,
981.5035).
3.2. Plant material
3
.3.4. Erythrosaponin D (4)
2
0
The roots of Gardenia erythroclada Kurz (synonym Dioecrescis
Amorphous powder; ½aꢀ -103.13 (c 0.32, MeOH); IR (KBr)
n
max
D
ꢁ1
1
13
erythroclada) (Rubiaceae) were collected in July 2015 and the stem
bark of G. erythroclada was collected in January 2016 from Sahat-
3423, 1727, 1642 cm
;
H and C NMR data, see Tables 1 and 3;
þ
positive HRESIMS m/z 817.4349 [Mþ Na] (calcd. for C42
66
H O14Na,
ꢃ
0
00
ꢃ
0
00
sakhan district, Kalasin province, Thailand (16 43 35 N 103 29 22
817.4350).
E). The plant material was identified by Dr. Suttira Khumkratok, a
botanist at the Walai Rukhavej Botanical Research Institute,
Mahasarakham University, and a specimen retained as a reference
3.3.5. Erythrosaponin E (5)
2
0
Amorphous powder; ½aꢀ -82.5 (c 0.20, MeOH); IR (KBr)
n
max
D
ꢁ1
1
13
(
Khumkratok no. 5e12).
3431, 1730, 1648 cm
; H and C NMR data, see Tables 1 and 3;